Founded in 2022, Longevity Biomedical, Inc. is a clinical-stage biomedical company based in Bothell, Washington, USA.
Our company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span.
The company’s leading clinical-stage programs are aimed at soft tissue repair, corneal transplant, ischemic stroke, and retinal vein occlusion; devastating conditions with limited treatment options that affect millions of patients worldwide each year.
In the pursuit of developing new breakthrough treatments to address unmet medical needs, we adhere to the following core values
We strive to use proven science to develop breakthrough medical therapies that extend and improve the quality of patients’ lives.
We are committed to the relentless pursuit of achieving our goals. Always moving forward, we celebrate our successes and learn from our mistakes.
We strive to always do the right thing, in an honest, fair, and responsible way.
We are committed to demonstrating the utmost respect to our employees, customers, and stakeholders. We respect individual human rights and oppose all kinds and forms of discrimination, whether based on religion, belief, race, ethnicity, nationality, gender, sexual orientation, or physical ability.
Longevity Biomedical, Inc
12100 NE 195th st. Suite 150
Bothell, WA 98011
+1 (425) 748-7529
info@longevitybiomedical.com
© 2022-2023 Longevity Biomedical Inc